Francesca Guijarro

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Foamy cell infiltration as a morphological challenge: Histiocytosis versus plasma cell neoplasm.

Foamy cell infiltration as a morphological challenge: Histiocytosis versus plasma cell neoplasm.

Journal: British journal of haematology

Published: June 04, 2026

Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Journal: Blood advances

Published: October 29, 2025

Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms Predisposition.

Performance and Clinical Utility of Spanish Germline Genetic Testing Criteria for Hematologic Neoplasms Predisposition.

Journal: Blood advances

Published: October 29, 2025

Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

Journal: Blood cancer journal

Published: February 11, 2025

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study.

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study.

Journal: Experimental hematology & oncology

Published: December 26, 2024

A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.

A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias.

Journal: Leukemia

Published: November 18, 2024

At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.

At-Home Care Program for Acute Myeloid Leukemia Induction Phase in Patients Treated with Venetoclax-Based Low-Intensity Regimens.

Journal: Cancers

Published: November 04, 2024

CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases.

CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases.

Journal: Diagnostic pathology

Published: October 22, 2024

Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics.

Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics.

Journal: British journal of haematology

Published: September 18, 2024

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.

Real-life outcome after failure to venetoclax and hypomethylating-based therapy for acute myeloid leukemia.

Journal: Haematologica

Published: September 07, 2024

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.

Whole Exome Sequencing of Intermediate-Risk Acute Myeloid Leukemia without Recurrent Genetic Abnormalities Offers Deeper Insights into New Diagnostic Classifications.

Journal: International journal of molecular sciences

Published: June 17, 2024

Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study.

Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study.

Journal: Annals of hematology

Published: May 31, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026